Clinical Validation of Unani Pharmacopoeial Formulation Sharbat-e-Ejaz in Sual-e-Yabis (Dry Cough)
Acta Pharma Reports · 02.09.2022 · 1 (2) · 1-3
DOI: 10.51470/apr.2022.01.02.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharma Reports, online erschienen am 25.09.2022. Verfasst von Irfan Ahmed und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Sual-e-Yabis (dry cough) is a common respiratory ailment described in classical Unani texts as a condition primarily of Yabusiyat (dryness) affecting the respiratory tract. Sharbat-e-Ejaz is a compound Unani formulation included in the Unani Pharmacopoeia of India (UPI) with documented anti-tussive and mucolytic properties.
Objective
To clinically validate the efficacy and safety of Sharbat-e-Ejaz in patients with Sual-e-Yabis through a multi-centre open-label clinical trial.
Methods
A total of 128 patients (Male: 88, Female: 40) with confirmed diagnosis of Sual-e-Yabis were enrolled from four CCRUM research institutes. The formulation was administered orally for four weeks with assessments at baseline, 2nd week (1st follow-up) and 4th week (end of treatment). Primary outcome was assessed using the Visual Analogue Scale (VAS). Laboratory investigations including haematological and biochemical parameters were performed to assess safety.
Results
Mean VAS score significantly decreased from 7.91 ± 1.35 at baseline to 2.69 ± 1.18 at end of treatment, reflecting a 65.9% reduction (p < 0.001). No clinically significant adverse changes were observed in laboratory parameters.
Conclusion
Sharbat-e-Ejaz demonstrated significant clinical efficacy and acceptable safety profile in the management of Sual-e-Yabis, supporting its validation as a standard Unani therapeutic formulation.
Zitieren
APA
Ahmed, I., Shaikh, N., Alam, M. M., Shah, A., Sheeraz, M., & Anjum, N. (2022). Clinical Validation of Unani Pharmacopoeial Formulation Sharbat-e-Ejaz in Sual-e-Yabis (Dry Cough). Acta Pharma Reports, 1(2), 1-3. https://doi.org/10.51470/apr.2022.01.02.01
Vancouver
Ahmed I, Shaikh N, Alam MM, Shah A, Sheeraz M, Anjum N. Clinical Validation of Unani Pharmacopoeial Formulation Sharbat-e-Ejaz in Sual-e-Yabis (Dry Cough). Acta Pharma Reports. 2022;1(2):1-3. doi:10.51470/apr.2022.01.02.01
BibTeX
@article{Ahmed2022,
author = {Ahmed, Irfan and Shaikh, Nikhat and Alam, MD Manzar and Shah, Arjumand and Sheeraz, Mohammed and Anjum, Nighat},
title = {Clinical Validation of Unani Pharmacopoeial Formulation Sharbat-e-Ejaz in Sual-e-Yabis (Dry Cough)},
journal = {Acta Pharma Reports},
year = {2022},
volume = {1},
number = {2},
pages = {1--3},
doi = {10.51470/apr.2022.01.02.01}
}
EUVIMED